← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3237)
- Dynamics of peripheral blood inflammatory index predict tumor pathological response and survival among patients with locally advanced non-small cell lung cancer who underwent neoadjuvant immunochemotherapy: a multi-cohort retrospective study. (2024/07/23) ♡
- Integrated network pharmacology and metabolomics to reveal the mechanism of Pinellia ternata inhibiting non-small cell lung cancer cells. (2024/07/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy. (2024/07/11) ♡
- Analysis of risk factors of postoperative complication for non-small cell lung cancer. (2024/07/10) ♡
- Pain and Coping Strategies as Determinants of Malnutrition Risk in Lung Cancer Patients: A Cross-Sectional Study. (2024/07/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Overcoming Chemoresistance in Cancer: The Promise of Crizotinib. (2024/07/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epithelial-mesenchymal transition (EMT) and its role in acquired epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) chemoresistance in non-small cell lung cancer (NSCLC). (2024/07/06) ♡
- Oral administration of oligo fucoidan improves the survival rate, quality of life, and immunity in patients with lung cancer. (2024/07/03) ♡
- Role of circulating microRNAs in non-small cell lung carcinoma. (2024/07/01) ♡
- Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway. (2024/07/01) ♡
- Integrative oncology for patients with lung cancer: A prospective pragmatic controlled trial. (2024/07/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: A meta-analysis. (2024/07/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pre-Operative Measures of Systemic Inflammation Predict Survival After Surgery for Primary Lung Cancer. (2024/07/01) ♡
- Tumor metabolic activity is associated with subcutaneous adipose tissue radiodensity and survival in non-small cell lung cancer. (2024/07/01) ♡
- Biologically Interpretable Model for Precise Recurrence Prediction of Non-Small Cell Lung Cancer. (2024/07/01) ♡
- Development of a Multiscale Mechanistic Model for Predicting Tumor Response to Anti-miR-155. (2024/07/01) ♡
- Hard example mining in Multi-Instance Learning for Whole-Slide Image Classification. (2024/07/01) ♡
- Knowledge Models for Cancer Clinical Practice Guidelines: Construction, Management, and Usage in Question Answering. (2024/07/01) ♡
- A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer. (2024/06/30) ♡
- Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway. (2024/06/28) ♡
- Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy. (2024/06/25) ♡
- Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer. (2024/06/24) ♡
- Circulating tumor DNA kinetics: A future tool for radiation therapy personalization in lung cancer? (2024/06/21) ♡
- Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report. (2024/06/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Bayesian network meta-analysis of EGFR-tyrosine kinase inhibitor treatments in patients with EGFR mutation-positive non-small cell lung cancer. (2024/06/21) ♡
- The survival and cost-effectiveness analysis of adjunctive Chinese medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan. (2024/06/20) ♡
- Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. (2024/06/20) ♡
- Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer. (2024/06/20) ♡
- Value of prognostic nutritional index and controlling nutritional status score for advanced non-small cell lung cancer patients receiving PD-1 inhibitors. (2024/06/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research. (2024/06/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Twenty-five years with HER2 targeted therapy. (2024/06/10) ♡
- A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers. (2024/06/10) ♡
- Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti-PD‑1 inhibitors based on the absolute counts of lymphocyte subsets. (2024/06/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study. (2024/06/03) ♡
- Predictors of Early Hospice or Death in Patients With Inoperable Lung Cancer Treated With Curative Intent. (2024/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pathologic Response Evaluation in Neoadjuvant-Treated Lung Cancer. (2024/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer. (2024/06/01) ♡
- Molecular Testing in Lung Cancer: Recommendations and Update. (2024/06/01) ♡
- Applications of Artificial Intelligence in Lung Pathology. (2024/06/01) ♡
- Ailanthone inhibits non-small cell lung cancer growth and metastasis through targeting UPF1/GAS5/ULK1 signaling pathway. (2024/06/01) ♡
- Identifying Anti-NSCLC Bioactive Compounds in Scutellaria via 2D NMR-Based Metabolomic Analysis of Pharmacologically Classified Crude Extracts. (2024/06/01) ♡
- Study on pharmacokinetics and tissue distribution of deoxypodophyllotoxin and its metabolites in tumour-bearing mice. (2024/06/01) ♡
- [Chemical constituents from Clitocybe clavipes and their antitumor activities]. (2024/06/01) ♡
- Multimodal prehabilitation in patients with non-small cell lung cancer: a feasibility study. (2024/05/31) ♡
- Machine Learning for Prediction of Non-Small Cell Lung Cancer Based on Inflammatory and Nutritional Indicators in Adults: A Cross-Sectional Study. (2024/05/30) ♡
- Blood-based DNA methylation markers for lung cancer prediction. (2024/05/30) ♡
- Prognostic factors and predictive model construction in patients with non-small cell lung cancer: a retrospective study. (2024/05/24) ♡
- Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis. (2024/05/23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study. (2024/05/17) ♡
- Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer. (2024/05/17) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.